StimuSIL
StimuSIL is a medical device company in the process of developing new technologies for safer and more effective photobiomodulation (PBM) therapy, with the goal of targeting multiple indications in dermatology and aesthetics. StimuSIL’s proprietary technologies aim to deliver PBM across the melanin layer of the skin in order to enhance this treatment’s biostimulatory effects. StimuSIL was established in January 2020 in Washington, D.C. by Pablo Villalba Villar.
stimusil.comCompany Details
Founded
- 2020
Employees
- Between 5 - 10 employees
Raised
- $2,327,572
Public
- No
Acquired
- No
Founders
- Pablo Villalba
Company Collections
These are collections StimuSIL is a part of. Click on the collection name to view similar companies.
StimuSIL's Industries
StimuSIL Headquarters Location
Total Amount Raised: $2,327,572
StimuSIL Funding Rounds
Series Unknown
$599,988
Series Unknown
$1,103,787
Seed
$48,799
Seed
$574,998
StimuSIL Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on StimuSIL.